B717/LIC-101 complex (Nippon Shinyaku)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameB717/LIC-101 complex (Nippon Shinyaku)
Drug Alias Namebcl-2 inhibiting siRNA/LIC-101 liposome complex (Nippon Shinyaku)
ClassificationBiologics
Mechanisms of ActionApoptosis regulator Bcl-2 inhibitors
TargetsApoptosis regulator Bcl-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Shinyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Shinyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A